Chris Parker

Chris Parker is responsible for sales, marketing and business development at Cellular Dynamics International. Mr. Parker brings more than 20 years of experience in the life science industry to CDI.

As a Vice President at Affymetrix, he managed all aspects of sales and marketing for the Global Pharmaceutical Business Unit. Mr. Parker led the sales efforts that grew Affymetrix to over $350 million per year in revenue within 8 years. Prior to his position in the Global Pharmaceutical Business Unit, Mr. Parker was responsible for market development of Affymetrix's genetics business and flagship products, establishing key contacts and key applications that drove the growth of the genome scanning market and chromosomal copy number applications.

Mr. Parker's professional background also includes serving on the drug discovery services team at Amersham Pharmacia and over a decade of research in molecular and cellular biology in the Department of Human Oncology at the University of Wisconsin-Madison, Comprehensive Cancer Center. While there, he worked with notable investigators, including V. Craig Jordan, to develop important cancer drugs such as Tamoxifen.